General Session

• Describe dynamics in Congress that are impacting health care policy.    
• Discuss federal legislative and regulatory key advocacy issues impact hospital pharmacies.
• Discuss how AI can enhance efficiency, accuracy, and patient-centric care.
• Discuss real-world examples showcasing the transformative impact of AI in pharmacy services.     
• Give examples of steps government agencies have taken to address drug shortages. (pharmacy technicians)    
• Discuss case studies highlighting the successful integration of AI in healthcare facilities. (pharmacy technicians)

Operations Session

• Describe eICU setting and clinical pharmacy collaboration.
• Explain clinical pharmacy intervention leveraging telehealth technology.
• Consider extending clinical pharmacy service to inpatient telehealth service lines.
• Describe different methods of communicating drug shortages.
• Explain ways to access drug shortages and develop mitigation strategies.    
• Identify the two primary barriers a patient may face gaining access to medications.
• Assess the applied methods for application within your institution.    
• Identify common barriers to pharmacist participation in research projects.
• Explain how pharmacy practice model may impact protected time for pharmacists to engage in non-traditional job duties.
• Discuss potential paradigm shifts to facilitate a pharmacy-centric culture of research.
• Describe the steps needed to identify and adopt a compounding recipe for institutional use.
• Explain the financial impact of internally compounding diclofenac suppositories at OhioHealth.    
• Explain the purpose of using a screening tool to identify potential adverse events.
• Describe the value of incorporating clinician review into an opioid reversal screening process.    
• Describe a novel workflow allowing for the dispensing of methadone from inpatient pharmacies upon discharge of patients with opioid use disorder.    
• Discuss the impact of the novel workflow in patient outcomes post-implementation.

Clinical Session

• Describe changes made to improve the safety and quality of heparin therapy.
• Identify key stakeholders to include when planning a change to a high alert medication.
• List the impact an infectious diseases pharmacist has on transitions of care and the revenue generation possible through OPAT.
• Design a plan for capture of leaked revenue through OPAT services.
• Evaluate the effectiveness of an interdisciplinary care team involving pharmacists by utilizing a GDMT score calculator to facilitate the initiation and up-titration of GDMT in the outpatient and inpatient setting compared to the usual care.
• Identify the benefits of pharmacist involvement within a hospital's stroke team.
• Develop a process to improve a Certified Advanced Primary Stroke Centers door to needle times.
• Explain the challenges faced by Emergency Departments in managing bleeds for patients with hemophilia.
• Describe the importance of timely administration of replacement factor in patients with hemophilia.
• Describe the process for creating patient-level risk-adjusted antimicrobial benchmarks using the Vizient CDB-RM.
• Determine the clinical impact of narrow-spectrum versus broad-spectrum antimicrobial use for patients with community-acquired pneumonia.
• Describe antimicrobial utilization in transplant patients (allogeneic, autologous, and CAR-T). 
• Interpret antimicrobial utilization data to target areas for intervention in a transplant population. 

RESx Session

• Review controlled substance workflows within an acute care hospital.    
• Identify opportunities to improve controlled substances workflows.
• Describe the process of implementation of an IV workflow management system.    
• Describe how to determine the products made on a compounding robot.
• State the operational considerations that should be assessed prior to installation of a sterile compounding robot.
• Classify the multidisciplinary approach of implementing BCMA in the OR.     
• Evaluate the implementation of advanced preparation at UC Davis Medical Center including the impact on institution costs and personnel workflow.    
• Explain the importance of optimizing sedation management in pediatric intensive care units (PICUs) to mitigate the risk of adverse effects.    
• Recognize potential opportunities to support appropriate duration of DAPT therapy for patients post-PCI.    
• Define Guideline-Directed Medication Therapy (GDMT) for Heart Failure.
• Describe the Pharmacist’s role in improving GDMT prescribing.
• Highlight operational improvements through implementation of technology and automation in a health-system specialty pharmacy.    
• Describe the key steps in the prioritization timeline for the acquisition of a local community hospital and apply the lessons learned to improve future healthcare system integrations.    
• Discuss the different aspects of an individual's journey that pertain to leadership planning, resilience and growth.      
• Describe the utility of an advanced pharmacist license and the strategies for reimbursement.

Administration Session

• Differentiate Workforce Development Strategies in Healthcare.
• Analyze the Impact of Career Ladder Restructuring.
• Apply External Partnerships in Workforce Development.
• Describe the benefits of stay interviews for employees and organizations.
• Discuss the steps to conduct stay interviews with work unit employees.    
• Describe the groundwork and initial steps needed to successfully implement a hospital wide credentialing and privileging process for pharmacists.
• Outline ongoing support required for practice performance evaluations and expansion of this process throughout the institution.    
• Identify continuous improvement methods used to improve 340B program management.

CPO Session

• Explain the complexities of handling cell and gene therapy medications in a health system.
• Identify challenges from member experiences related to pharmacy departments.
• Apply areas of improvement or opportunities for health systems multidisciplinary teams.
• Discuss real-world examples of high reliability organizations, successes and learnings through stories.
• Recognize the role of leadership and culture in fostering high reliability within an organization.
• Identify meaningful actions for implementing high reliability practices and creating a culture of safety in your organization.